Cuban Patients Benefited from #HeberprotP Grow

By Alma

Ciego de Avila, Cuba.- Foot amputations in people with diabetes decreased in Cuba due to the use of Heberprot-P, a specialist said today.

Lianet Rodriguez, national promoter of the Comprehensive Care Program for patients with diabetic foot ulcers, told reporters that Ciego de Avila ranks as the most prominent province of the island using the Cuban medicine, which is unique in the world for treating the ailment.

Sigue leyendo

Anuncios

Over 220,000 Patients in the World Benefited from Heberprot-P

web@radiorebelde.icrt.cu

Tomada de Radio Angulo

More than 220,000 patients in 30 countries benefit from the use of the Cuban medicine Heberprot-P, unique of its kind and marketed by Cuba, which reduces the rate of diabetic foot amputation.

The benefits and impact that Heberprot-P causes internationally contribute to the increase of interest, according to data provided to Radio Rebelde by Raudel Sosa, promoter of the Center for Genetic Engineering and Biotechnology in Havana.

Sigue leyendo

#Heberprot-P which produces #Cuba benefits #Russia. In #US it is not possible (+ video)

By Alma

The clinical trials for the implementation of the Cuban biopharmaceutical drug Heberprot-P in patients with diabetic foot in Russia show today the effectiveness of the medicine, with prospects of being extended to a larger number of regions.

Sigue leyendo